Hemay001

N/A

Report date: 2024/12/03 16:48:11
NME

Base Information

Drug NameHemay001
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTumor necrosis factor α inhibitors
TargetsTumor necrosis factor α
Therapy Area/IndicationsPsoriasisDermatitis, AtopicPulmonary Disease, Chronic Obstructive +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesTianjin Hemay Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesTianjin Hemay Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsPsoriasisDermatitis, AtopicPulmonary Disease, Chronic Obstructive +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A